3/A

PRIMARY DOCUMENT

Company: Raphael Pharmaceutical Inc.
Filed: October 3, 2008
Period of Report: December 18, 2007
Accession Number: 0001165527-08-000570

View Document ↗ View on SEC.gov ↗